OCLN and inflammatory bowel disease: As mentioned previously, alteration of TJs was already noticed in IBD patients long ago, for example the overexpression of Claudin-2 [166,167] and downregulation or redistribution of Occludin, Claudin-5, Claudin-8 [167] and Claudin-3, and Claudin-4 [166].